June 20, 2024
Looking for FDA-Recognized Susceptibility Test Interpretive Criteria? Looking for recent updates? Please see: Notices of Updates Sign up to receive FDA Recognized Antimicrobial STIC Breakpoints email […]
June 20, 2024
TOPLINE: Repeated low-level red light (RLRL) therapy reduces axial elongation and stabilizes refractive error in children and adolescents with high myopia. METHODOLOGY: Researchers conducted a randomized […]
June 20, 2024
It seems intuitive that because people with type 2 diabetes (T2D) generally need to avoid sugar, clinicians should recommend eating foods and using recipes containing artificial […]
June 20, 2024
[6/20/2024] Today, FDA issued a draft guidance for industry “Considerations for Demonstrating Interchangeability with a Reference Product: Update.” This draft guidance describes considerations regarding a switching […]
June 20, 2024
“My weight has always been kind of an issue,” said Gerald Fernandez, a 33-year-old mortgage broker in Naples, Florida. Over the years, he has sought advice […]
June 20, 2024
Regular walking can help prevent recurrent episodes of low back pain, a new study suggests. Among adults who recently recovered from an episode of low back […]
June 20, 2024
Docket Number: FDA-2017-D-0154 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research This guidance is intended to assist […]
June 20, 2024
TOPLINE: In patients with type 1 diabetes (T1D), sodium-glucose cotransporter 2 (SGLT2) inhibitors plus glucagon receptor antagonists (GRAs) may improve glycemic control, reduce insulin use, and […]
June 20, 2024
FDA-approved biosimilars are safe and effective biologic medications that are highly similar to biologic medications already approved by FDA – called “reference products.” There are no […]